𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prompt response to rituximab of severe hemolytic anemia with both cold and warm autoantibodies

✍ Scribed by Duncan Webster; Bruce Ritchie; Michael J. Mant

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
48 KB
Volume
75
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

A 71‐year‐old male with severe autoimmune hemolysis with both cold agglutinins and warm antibodies was intolerant of prednisone and cyclophosphamide. Rituximab was given during a 60‐day period when he required 41 units of packed cells to maintain hemoglobin above 75 g/l. Two weeks later hemoglobin stabilized at 95 g/l, and further transfusions were not required. A second course of rituximab was given 4 months later for continued hemolysis. A satisfactory hemoglobin was maintained for 9 months from initial treatment, when hemoglobin again fell to 65 g/L. A prompt response to a third course of rituximab was obtained. This is the second patient with both cold agglutinins and warm antibodies with severe hemolytic anemia who has had a prompt response to rituximab. This treatment should be considered when a rapid response is needed or when a patient has failed to respond to more standard therapies. Am. J. Hematol. 75:258–259, 2004. © 2004 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Severe hemolytic anemia due to cold aggl
Severe hemolytic anemia due to cold agglutinin complicating untreated chronic hepatitis C: Efficacy and safety of anti-CD20 (rituximab) treatment
✍ Anne Etienne; Stéphane Gayet; Florian Vidal; Pascale Poullin; Corinne Brunet; Je 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB 👁 2 views

## Abstract Autoimmune hemolytic anemia (AIHA) is rare and difficult to treat during chronic hepatitis C. We report herein the case of a hepatitis C patient with severe and resistant AIHA who experienced a good and sustained response with anti‐CD20 monoclonal antibody treatment. Am. J. Hematol. 75:

Successful anti-CD20 monoclonal antibody
Successful anti-CD20 monoclonal antibody treatment of severe autoimmune hemolytic anemia due to warm reactive IgM autoantibody in a child with common variable immunodeficiency
✍ Mary Wakim; Ami Shah; Patricia A. Arndt; George Garratty; Kenneth Weinberg; Thom 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

## Abstract Autoimmune hemolytic anemia due to warm reactive IgM autoantibodies is unusual, severe, and often fails to respond to standard immunosuppressive therapies in both adults and children. A 6‐year‐old girl with common variable immunodeficiency had longstanding steroid dependent, splenectomy